SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim B who wrote (2014)6/28/1998 8:24:00 PM
From: Striyker  Read Replies (2) of 5402
 
***TO ALL***

Well, it looks as though we have raised some interest in our latest discusion. I was PM'd by someone who would like their name to remane silent. I asked if I could post the message following and they agreed to do so under the condition their name not be revealed. Please respond to me and I will pass this info on. Thank you for understanding. I am not sure of the scientist's names mentioned other than Dr. Dreese. If you know, tell me and I'll pass it on. "They" have agreed to supply me any info gathered. Again, thank you and "They". Message follows,

"Am a consultant in pre-clinical trials for a pharma company. Will say that it is more than likely that any company that is working in the field of a blood substitute, already knows about Sanguine. They have probably already done their own assays on the product to check it out.

First: I am not very familiar with SGNC and have only read parts of this thread.

Second: Would wonder if the animal trials that are being done at Battelle are Primate trials. These are VERY expensive....Battelle is the best at Primate studies so I'm wondering if this is true.

Third: Wonder where the money is coming from to pay Battelle?

Fourth: Would think that SGNC's best bet is for a buyout.

Fifth: Don't call Baxter or J&J. Biotech is a small world. Many of the scientists working on a blood substitute already know each other. Some may have worked together already.

Sixth: I will ask some of my contacts if they have heard anything about the principal players in this venture. Get me the names of the scientists and I'll check. My contacts are excellent genetic engineers who were key players in the cloning and development of TPA for Genentech.

Hope this helps!"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News